Tenax Therapeutics (TENX) Net Margin (2011 - 2015)

Tenax Therapeutics (TENX) has 4 years of Net Margin data on file, last reported at 9877.81% in Q2 2015.

• For the quarter ending Q2 2015, Net Margin changed N/A year-over-year to 9877.81%; the trailing twelve-month figure through Jun 2016 stood at 12031.27% (up 1243448.0% YoY), and the FY2015 full-year result was 40331.1%, changed N/A from the prior year.
• Net Margin fell to 9877.81% in Q2 2015, from 2134.16% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 6427.01% in Q2 2011 to a low of 11513.99% in Q3 2011.
• A 4-year average of 2497.79% and a median of 1222.53% in 2012 frame the typical range for Net Margin.
• Peak annual rise in Net Margin reached 1285954 bps in 2012, while the deepest fall reached 917777 bps in 2012.
• Tracing TENX's Net Margin over 4 years: stood at 6298.92% in 2011, then jumped by 105 bps to 305.69% in 2012, then jumped by 598 bps to 2134.16% in 2013, then slumped by 563 bps to 9877.81% in 2015.
• Business Quant data shows TENX's Net Margin at 9877.81% in Q2 2015, 2134.16% in Q2 2013, and 1085.02% in Q1 2013.